Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B(2024) Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials Mol Oncol(in press) DOI 10.1002/1878-0261.13675, PubMed 38978352
Sharma A, Debik J, Naume B, Ohnstad HO, Oslo Breast Cancer Consortium (OSBREAC), Bathen TF, Giskeødegård GF(2024) Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes Oncogenesis, 13(1), 22 DOI 10.1038/s41389-024-00521-6, PubMed 38871719
Ohnstad HO, Blix ES, Akslen LA, Gilje B, Raj SX, Skjerven H, Borgen E, Janssen EAM, Mortensen E, Brekke MB, Falk RS, Schlichting E, Boge B, Songe-Møller S, Olsson P, Heie A, Mannsåker B, Vestlid MA, Kursetgjerde T, Gravdehaug B, Suhrke P, Sanchez E, Bublevic J, Røe OD, Geitvik GAet al.(2024) Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1) ESMO Open, 9(6), 103475 DOI 10.1016/j.esmoop.2024.103475, PubMed 38838499